58 related articles for article (PubMed ID: 27346189)
1. International trade and determinants of price differentials of insulin medicine.
Helble M; Aizawa T
Health Policy Plan; 2017 Feb; 32(1):1-10. PubMed ID: 27346189
[TBL] [Abstract][Full Text] [Related]
2. Increasing Divergence in Drug Prices Between the United States and Germany After Implementation of Comparative Effectiveness Analysis and Collective Price Negotiations.
Berkemeier F; Whaley C; Robinson JC
J Manag Care Spec Pharm; 2019 Dec; 25(12):1310-1317. PubMed ID: 31778624
[TBL] [Abstract][Full Text] [Related]
3. Affordable and equitable access to subsidised outpatient medicines? Analysis of co-payments under the Additional Drug Package in Kyrgyzstan.
Vogler S; Schneider P; Dedet G; Bak Pedersen H
Int J Equity Health; 2019 Jun; 18(1):89. PubMed ID: 31196109
[TBL] [Abstract][Full Text] [Related]
4. Pricing appraisal of anti-cancer drugs in the South East Asian, Western Pacific and East Mediterranean Region.
Salmasi S; Lee KS; Ming LC; Neoh CF; Elrggal ME; Babar ZD; Khan TM; Hadi MA
BMC Cancer; 2017 Dec; 17(1):903. PubMed ID: 29282008
[TBL] [Abstract][Full Text] [Related]
5. Impact of external price referencing on medicine prices - a price comparison among 14 European countries.
Leopold C; Mantel-Teeuwisse AK; Seyfang L; Vogler S; de Joncheere K; Laing RO; Leufkens H
South Med Rev; 2012 Dec; 5(2):34-41. PubMed ID: 23532710
[TBL] [Abstract][Full Text] [Related]
6. Medicines prices in International (Geary-Khamis) Dollar. The comparison between regulated and deregulated markets.
Zaprutko T; Cynar J; Sygit M; Stolecka A; Skorupska P; Jaszcz P; Kopciuch D; Paczkowska A; Ratajczak P; Kus K
PLoS One; 2024; 19(6):e0304400. PubMed ID: 38848422
[TBL] [Abstract][Full Text] [Related]
7. A Study of Comparative Advantage and Intra-Industry Trade in the Pharmaceutical Industry of Iran.
Yusefzadeh H; Rezapour A; Lotfi F; Ebadifard Azar F; Nabilo B; Abolghasem Gorji H; Hadian M; Shahidisadeghi N; Karami A
Glob J Health Sci; 2015 Apr; 7(6):295-307. PubMed ID: 26153184
[TBL] [Abstract][Full Text] [Related]
8. Reference Pricing with Endogenous or Exogenous Payment Limits: Impacts on Insurer and Consumer Spending.
Brown TT; Robinson JC
Health Econ; 2016 Jun; 25(6):740-9. PubMed ID: 25903495
[TBL] [Abstract][Full Text] [Related]
9. Comparing Insulin Prices in the United States to Other Countries: Updated Results Using 2022 Data.
Mulcahy AW; Schwam D
Rand Health Q; 2024 Jun; 11(3):3. PubMed ID: 38855388
[TBL] [Abstract][Full Text] [Related]
10. Cross-country comparisons in health price growth over time.
Papanicolas I; Cylus J; Lorenzoni L
Health Serv Res; 2024 Mar; ():. PubMed ID: 38454562
[TBL] [Abstract][Full Text] [Related]
11. Preliminary Examination of an Appropriate Price Calculation Method and Medical Treatment Costs for Foreign Visitors in Japan.
Takura T; Study Group Research On Appropriate Medical Treatment Prices For Foreigners Visiting Japan
Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34072299
[TBL] [Abstract][Full Text] [Related]
12. The international diffusion of food innovations and the nutrition transition: retrospective longitudinal evidence from country-level data, 1970-2010.
Disdier AC; Etilé F; Rotunno L
BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 37967902
[TBL] [Abstract][Full Text] [Related]
13. Trade in medicines and the public's health: a time series analysis of import disruptions during the 2015 India-Nepal border blockade.
Sharma A; Mishra SR; Kaplan WA
Global Health; 2017 Aug; 13(1):61. PubMed ID: 28830500
[TBL] [Abstract][Full Text] [Related]
14. Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care.
Shih YT; Nasso SF; Zafar SY
Pharmacoeconomics; 2018 Mar; 36(3):259-261. PubMed ID: 29396743
[No Abstract] [Full Text] [Related]
15. Low risk, high reward? Repeated competitive biddings with multiple winners in health care.
Pitkänen V; Jauhiainen S; Linnosmaa I
Eur J Health Econ; 2020 Jun; 21(4):483-500. PubMed ID: 31902025
[TBL] [Abstract][Full Text] [Related]
16. Will pay-per-view in the advanced charging model recover the business losses for online video companies in China?
Zhang C; Phoong SW
PLoS One; 2024; 19(1):e0297977. PubMed ID: 38295093
[TBL] [Abstract][Full Text] [Related]
17. Decomposition of Expenditures for Insulins Across the Distribution Chain-Insights Into Rising Prices?
Good CB; Hernandez I
JAMA Health Forum; 2021 Nov; 2(11):e212258. PubMed ID: 36218843
[No Abstract] [Full Text] [Related]
18. Cyclicality, Mortality, and the Value of Time: The Case of Coffee Price Fluctuations and Child Survival in Colombia.
Miller G; Urdinola BP
J Polit Econ; 2010 Feb; 118(1):113-155. PubMed ID: 22090662
[TBL] [Abstract][Full Text] [Related]
19. Lawsuits Over the Price of Insulin-State Efforts for Insulin Access.
Aaron DG; Cohen IG; Adashi EY
JAMA Intern Med; 2024 Jan; 184(1):9-10. PubMed ID: 38048078
[TBL] [Abstract][Full Text] [Related]
20. Out-of-pocket expenses and rationing of insulin and diabetes supplies: findings from the 2022 T1International cross-sectional web-based survey.
Souris KJ; Pfiester E; Thieffry A; Chen Y; Braune K; Kapil Bhargava M; Samra R; Gómez P; O'Donnell S
Front Clin Diabetes Healthc; 2024; 5():1293882. PubMed ID: 38711747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
